Saudi Journal of Anaesthesia

ORIGINAL ARTICLE
Year
: 2015  |  Volume : 9  |  Issue : 3  |  Page : 247--252

Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients


Ayman A Ghoneim1, Mohammed A El Beltagy2 
1 Department of Anesthesia and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt
2 Department of Neurosurgery, Faculty of Medicine, Cairo University, Cairo, Egypt

Correspondence Address:
Ayman A Ghoneim
Department of Anesthesia and Pain Management, National Cancer Institute, Cairo University, Cairo
Egypt

Background: Postoperative recurarization remains a risk following the use of the conventional neuromuscular blocking agents. In addition, none of the commonly used reversal agents, such as neostigmine or edrophonium are capable of reliably reversing profound blockade. The present comparative and randomized study investigated the use of sugammadex for reversing profound neuromuscular blockade (NMB) in pediatric neurosurgical patients undergone posterior fossa tumor excision. Patients and Methods: Forty pediatric patients undergoing elective craniotomy for posterior fossa tumor excision were randomly divided into either of neostigmine or sugammadex group in which muscle relaxant was reversed at the end of anesthesia either with neostigmine 0.04 mg/kg added to atropine 0.02 mg/kg or sugammadex 4 mg/kg alone, respectively. The primary endpoint was the time from the administration of sugammadex or neostigmine to recovery of the train of four (TOF) ratio to 90% after rocuronium-induced neuromuscular block. Unpaired t-test was used to compare continuous variables between groups. Meanwhile, repeated ANOVA was used to detect intragroup differences. Results: Patients in sugammadex group attained a TOF ratio 90% in statistically shorter time (1.4 ± 1.2 min) than those in neostigmine group (25.16 ± 6.49 min) for reversal of the rocuronium. Mean arterial pressure and heart rate were significantly higher in neostigmine group at 2, 5 and 10 min after administration of the reversal agents and returned nonsignificantly different after that. With no recurarization in any patient throughout the study period. Conclusion: Sugammadex rapidly and effectively reverses rocuronium-induced NMB in pediatric patients undergoing neurosurgery when administered at reappearance of T2 of TOF at dose 4 mg/kg.


How to cite this article:
Ghoneim AA, El Beltagy MA. Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients.Saudi J Anaesth 2015;9:247-252


How to cite this URL:
Ghoneim AA, El Beltagy MA. Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients. Saudi J Anaesth [serial online] 2015 [cited 2020 May 26 ];9:247-252
Available from: http://www.saudija.org/article.asp?issn=1658-354X;year=2015;volume=9;issue=3;spage=247;epage=252;aulast=Ghoneim;type=0